JTI UK Expands Nordic Spirit Line, Launches 17mg Nicotine Pouch

Oct.31
JTI UK Expands Nordic Spirit Line, Launches 17mg Nicotine Pouch
JTI UK has launched Nordic Spirit’s highest-strength variant—Frosty Mint Max, delivering 17mg of nicotine per pouch—and introduced a refreshed, darker packaging design for the brand.

Quick Take

 

  • The new product is labelled “Max” strength, delivering 17mg of nicotine per pouch; RRP £6.50 per can.
  • Now available via JTI360 and select supermarkets.
  • From 3 November, it will roll out to independent retailers and symbol-group stores.
  • A darker, bolder packaging refresh underscores the product’s “power” positioning.

 


2Firsts, October 31, 2025 — According to Convenience Store, Japan Tobacco International UK (JTI UK) has introduced Frosty Mint Max, the highest-nicotine variant in the Nordic Spirit range. Targeting demand for higher-strength nicotine pouches, the product sits in the “Max strength” segment with 17mg of nicotine per pouch.

 

JTI says the new variant carries a recommended retail price of £6.50 per can. It is already available through the JTI360 platform and grocery channels (grocers), and will roll out from next week (3 November) to independent retailers and symbol-group stores.

 

The launch also unveils a refreshed brand look for Nordic Spirit, using darker tones and stronger design cues to signal intensity and improve on-shelf standout.

 

James Richards, JTI UK’s brand lead, said Frosty Mint Max, as the highest-nicotine product in the range to date, will help retailers capture growth in the high-strength segment and further lift nicotine pouch category sales.

 

 

Cover image: Convenience Store

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Newport News, Virginia, USA, has passed new regulations requiring new e-cigarette shops to be approximately 610 meters away from schools
Newport News, Virginia, USA, has passed new regulations requiring new e-cigarette shops to be approximately 610 meters away from schools
New zoning regulations in Newport News, Virginia require e-cigarette shops to be at least 2000 feet from schools and daycares.
Sep.25 by 2FIRSTS.ai
Dutch survey: E-cigarettes containing synthetic cannabinoids are rampant in schools, endangering the health of minors
Dutch survey: E-cigarettes containing synthetic cannabinoids are rampant in schools, endangering the health of minors
An investigation by Dutch program Zembla found THC e-cigarettes with synthetic cannabinoids spreading quickly among schoolchildren. Lab tests confirmed the products are high-risk and potent, having caused students to vomit, faint, or be hospitalized. Addiction clinics report rising cases, and health officials warn educators of serious health and addiction risks.
Sep.12 by 2FIRSTS.ai
Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways
Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways
2Firsts analyzes vaping regulations across the Baltic states. Following Latvia’s flavor ban, tax revenues fell and the black market expanded, while similar measures in Estonia and Lithuania have also failed to deliver results. The region’s anti-vaping policies are now triggering market imbalance and policy reassessment.
Oct.13
Company | Ploom AURA’s First Overseas Launch in Switzerland Kicks Off Global Rollout
Company | Ploom AURA’s First Overseas Launch in Switzerland Kicks Off Global Rollout
Japan Tobacco International (JTI) has announced that its next-generation heated-tobacco device, Ploom AURA, has debuted in Switzerland, marking the start of its global launch plan. Switzerland plays a key role as JTI’s global headquarters location. Dagmersellen is one of only four facilities worldwide producing EVO filter mouthpieces, underlining Switzerland’s importance in the company’s global operations.
Sep.02 by 2FIRSTS.ai
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
FDA’s Makary on CNN: The Triple Challenge in Vape Regulation — New Opioids, Illicit Trade, and Youth Protection
In an interview with CNN’s Chasing Life, U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary warned that new health risks — from emerging opioids such as 7-OH to unregulated vaping products — are slipping through regulatory cracks. His remarks reveal the FDA’s growing challenge to balance harm reduction for adult smokers with youth protection and cross-border enforcement.
Oct.10
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai